1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Pete coming back?

Discussion in 'Mimedx' started by anonymous, May 3, 2019 at 1:44 PM.

  1. anonymous

    anonymous Guest

    Who’s excited that Pete may be coming back?
     
  2. anonymous

    anonymous Guest

    I’m stoked. His business acumen is unprecedented
     
  3. anonymous

    anonymous Guest

    So looking forward to the mad little tyrants return! Maybe he will bring back his drunk sidekick, the obese commercialization officer, the woman who dressed like she was going to the BET awards for the annual awards dinner and the CFO who wasn’t a CPA.